S Takenoshita Selected Research

S Takenoshita Research Topics

Disease

13	Neoplasms (Cancer) 09/2006 - 04/2000
5	Breast Neoplasms (Breast Cancer) 06/2001 - 01/2000
4	Colorectal Neoplasms (Colorectal Cancer) 06/2003 - 09/2000
3	Carcinogenesis 06/2003 - 08/2000
3	Colonic Neoplasms (Colon Cancer) 07/2001 - 07/2000
2	Neoplasm Metastasis (Metastasis) 06/2001 - 11/2000
2	Stomach Neoplasms (Stomach Cancer) 06/2001 - 09/2000
2	Ovarian Neoplasms (Ovarian Cancer) 12/2000 - 08/2000
1	Hypertension (High Blood Pressure) 01/2021
1	Insulin Resistance 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Gout 01/2021
1	Drug-Related Side Effects and Adverse Reactions 03/2017
1	Microsatellite Instability 09/2006
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2002
1	Hyperplasia 01/2002
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2002
1	Margins of Excision 06/2001
1	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2001
1	Pain (Aches) 11/2000
1	Esophageal Squamous Cell Carcinoma 10/2000
1	Lymphatic Metastasis 09/2000
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2000
1	Pleural Effusion (Pleural Effusions) 07/2000
1	Adenocarcinoma 07/2000
1	Lung Neoplasms (Lung Cancer) 07/2000
1	Primary Hyperparathyroidism 06/2000

Drug/Important Bio-Agent (IBA)

6	Transforming Growth Factor beta (TGF-beta)IBA 09/2006 - 07/2000
4	Transforming Growth Factor-beta Type II ReceptorIBA 09/2006 - 07/2000
3	DNA (Deoxyribonucleic Acid)IBA 06/2003 - 04/2000
3	Indicators and Reagents (Reagents)IBA 09/2000 - 01/2000
2	Fluorouracil (Carac)FDA LinkGeneric 07/2001 - 06/2001
2	Messenger RNA (mRNA)IBA 06/2001 - 08/2000
2	Codon (Codons)IBA 12/2000 - 08/2000
2	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 12/2000 - 08/2000
2	Proteins (Proteins, Gene)FDA Link 09/2000 - 08/2000
1	LDL CholesterolIBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	TeaIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	CholesterolIBA 01/2021
1	Psychotropic Drugs (Psychoactive Drugs)IBA 03/2017
1	technetium 99m methoxyisobutylisonitrileIBA 01/2002
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 11/2001
1	UDP-galactose translocatorIBA 06/2001
1	AntigensIBA 06/2001
1	CarbohydratesIBA 06/2001
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 06/2001
1	Sialyl Lewis X AntigenIBA 06/2001
1	E-SelectinIBA 06/2001
1	Thomsen-Friedenreich antigenIBA 06/2001
1	Complementary DNA (cDNA)IBA 06/2001
1	RheniumIBA 05/2001
1	Analgesics (Analgesic Drugs)IBA 11/2000
1	Pamidronate (Aredia)FDA LinkGeneric 11/2000
1	Therapeutic UsesIBA 11/2000
1	MidkineIBA 09/2000
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2000
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2000
1	Poly AIBA 07/2000
1	Transforming Growth Factor-beta Type I ReceptorIBA 07/2000
1	Epirubicin (Ellence)FDA LinkGeneric 07/2000
1	Goserelin (Zoladex)FDA Link 07/2000
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2000
1	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2000
1	Estrogen ReceptorsIBA 01/2000

Therapy/Procedure

3	Therapeutics 11/2000 - 07/2000
2	Drug Therapy (Chemotherapy) 06/2001 - 07/2000
1	Parathyroidectomy 01/2002
1	Minimally Invasive Surgical Procedures 01/2002
1	Subcutaneous Mastectomy 06/2001
1	Segmental Mastectomy (Lumpectomy) 06/2001
1	Analgesia 11/2000